169 related articles for article (PubMed ID: 30811692)
1. Modelling first-year cost-of-illness of melanoma attributable to sunbed use in Europe.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():46-56. PubMed ID: 30811692
[TBL] [Abstract][Full Text] [Related]
2. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
3. Cost-of-illness of melanoma in Europe - a systematic review of the published literature.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):504-510. PubMed ID: 30408246
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis.
Boniol M; Autier P; Boyle P; Gandini S
BMJ; 2012 Jul; 345():e4757. PubMed ID: 22833605
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer projections and cost savings 2014-2045 of improvements to the Danish sunbed legislation of 2014.
Køster B; Meyer MKH; Andersson TM; Engholm G; Dalum P
Photodermatol Photoimmunol Photomed; 2019 Mar; 35(2):78-86. PubMed ID: 30198585
[TBL] [Abstract][Full Text] [Related]
6. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
7. Melanoma attributable to sunbed use and tan seeking behaviours: an Italian survey.
Gandini S; Stanganelli I; Magi S; Mazzoni L; Medri M; Agnoletti V; Lombi L; Falcini F
Eur J Dermatol; 2014; 24(1):35-40. PubMed ID: 24334101
[TBL] [Abstract][Full Text] [Related]
8. Sunbeds and melanoma risk: time to close the debate.
Suppa M; Gandini S
Curr Opin Oncol; 2019 Mar; 31(2):65-71. PubMed ID: 30676536
[TBL] [Abstract][Full Text] [Related]
9. Modelling the healthcare costs of skin cancer in South Africa.
Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence, risk groups, and reasons for sunbed use in Germany].
Schneider S; Görig T; Breitbart EW; Greinert R; Diehl K
Hautarzt; 2016 Mar; 67(3):226-33. PubMed ID: 26779890
[TBL] [Abstract][Full Text] [Related]
11. A Critical Appraisal of the Recent Reports on Sunbeds from the European Commission's Scientific Committee on Health, Environmental and Emerging Risks and from the World Health Organization.
Reichrath J; Lindqvist PG; DE Gruijl FR; Pilz S; Kimball SM; Grant WB; Holick MF
Anticancer Res; 2018 Feb; 38(2):1111-1120. PubMed ID: 29374748
[TBL] [Abstract][Full Text] [Related]
12. Association of Indoor Tanning Regulations With Health and Economic Outcomes in North America and Europe.
Gordon LG; Rodriguez-Acevedo AJ; Køster B; Guy GP; Sinclair C; Van Deventer E; Green AC
JAMA Dermatol; 2020 Apr; 156(4):401-410. PubMed ID: 32074257
[TBL] [Abstract][Full Text] [Related]
13. The potential impact of reducing indoor tanning on melanoma prevention and treatment costs in the United States: An economic analysis.
Guy GP; Zhang Y; Ekwueme DU; Rim SH; Watson M
J Am Acad Dermatol; 2017 Feb; 76(2):226-233. PubMed ID: 27939556
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous melanoma in France in 2015 attributable to solar ultraviolet radiation and the use of sunbeds.
Arnold M; Kvaskoff M; Thuret A; Guénel P; Bray F; Soerjomataram I
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1681-1686. PubMed ID: 29706005
[TBL] [Abstract][Full Text] [Related]
15. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe.
Bataille V; Boniol M; De Vries E; Severi G; Brandberg Y; Sasieni P; Cuzick J; Eggermont A; Ringborg U; Grivegnée AR; Coebergh JW; Chignol MC; Doré JF; Autier P
Eur J Cancer; 2005 Sep; 41(14):2141-9. PubMed ID: 16125927
[TBL] [Abstract][Full Text] [Related]
16. Sunbed use and campaign initiatives in the Danish population, 2007-2009: a cross-sectional study.
Køster B; Thorgaard C; Philip A; Clemmensen H
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1351-5. PubMed ID: 21711466
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study).
Grange F; Mohr P; Harries M; Ehness R; Benjamin L; Siakpere O; Barth J; Stapelkamp C; Pfersch S; McLeod LD; Kaye JA; Wolowacz S; Kontoudis I
Melanoma Res; 2017 Dec; 27(6):607-618. PubMed ID: 28800027
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.
Lafuma A; Brézin A; Lopatriello S; Hieke K; Hutchinson J; Mimaud V; Berdeaux G
Pharmacoeconomics; 2006; 24(2):193-205. PubMed ID: 16460138
[TBL] [Abstract][Full Text] [Related]
19. Societal cost of skin cancer in Sweden in 2005.
Tinghög G; Carlsson P; Synnerstad I; Rosdahl I
Acta Derm Venereol; 2008; 88(5):467-73. PubMed ID: 18779884
[TBL] [Abstract][Full Text] [Related]
20. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
